Big pills big problem for Ethex?
Ethex has initiated its third recall of the year as yet again the spectre of dangerous oversized tablets casts its shadow over the St Louis-headquartered company’s manufacturing operations.
Archives for November 10, 2008
All change at the top for pharma’s top 10
Pfizer is likely to lose its crown as the world’s largest pharmaceutical company and by 2012 will be usurped by GlaxoSmithKline, according to a report from Urch Publishing.
AAPS preview
American Association of Pharmaceutical Scientist's (AAPS) president Dr Karen Habucky sets out the programme for the group's forthcoming annual meeting and exposition, which is being held in Atlanta, US between November 16- 20.
Novo looks east for $400m insulin plant
Danish drugmaker Novo Nordisk has unveiled an ambitious plan to build an insulin plant in China, tapping into a major new market for diabetes treatments.
Mayo pulls out of clinical services
The world-reknowned Mayo Clinic has decided to shut down its Mayo Clinical Trial Services unit, saying it has been unable to compete in a marketplace shifting towards “low-cost, routine trials.”
Contaminated heparin seized in US
US Marshals have entered Celsus Laboratories to seize 11 lots of heparin, which contain contaminated material from China according to the US Food and Drug Administration (FDA).
Patheon opens European headquarters
Patheon’s European HQ is up and running to help manage the firm’s growing European operations, specifically its development and commercial service offerings provided by units in France, Italy and the UK.
Honeywell inks China packaging deal
Honeywell has entered into a three-year agreement to supply its Aclar brand moisture-barrier films to Shanghai Haishun Packaging Material.
Cambrex cost-cutting helps in ‘difficult’ Q3
Cambrex joined a number of its peers in the contract services sector by reporting pressure on third quarter sales and earnings, providing further evidence that outsourcing companies are not immune to the economic downturn.
Cognis talks excipients
Dr Thomas Rosen discusses Cognis' new excipient TPGS, a water soluble form of vitamin E, and its applications in increasing bioavailability.